PART 4Hospitals (continued)
66 The person in charge of a hospital must record, or cause to be recorded, the following information:
(a) the brand name or, if the targeted substance does not have a brand name, the specified name, the quantity of any targeted substance received by the hospital and the date on which it was received;
(b) the name and address of the licensed dealer, pharmacist or other hospital that sold or provided the targeted substance;
(c) the name and quantity of the targeted substance sold, provided, administered, sent, delivered or transported, the name and address of the recipient and the date of the transaction; and
(d) the name and address of any out-patient to whom a targeted substance is sold or provided under section 64.
- SOR/2010-223, s. 30
67 If a targeted substance is stored in a hospital or the pharmacy department of a hospital and the hospital or department closes, the person in charge of the hospital must, not later than 10 days after the day of the closure, inform the Minister of the date of closure, the location to which the targeted substance was moved and the quantity of the targeted substance that was moved.
- SOR/2010-223, s. 31(E)
Marginal note:Importation — Canadian residents
68 (1) An individual who is a resident of Canada may, at the time of the individual’s return to Canada from a foreign country, import a targeted substance that is in their possession at the time of entry if
(a) the substance has been obtained under a prescription and is labelled with the information set out in paragraphs 51(2)(a) to (g);
(b) the individual is importing the substance
(c) the substance is imported to meet the medical needs of the individual or animal for whose benefit it is prescribed;
(d) the substance is declared to a customs office at the port of entry into Canada at the time of import; and
(e) the quantity being imported does not exceed the lesser of
Marginal note:Importation — foreign residents
(2) An individual who is a resident of a foreign country may, at the time that the individual enters Canada, import a targeted substance that is in their possession at the time of entry if
69 An individual may, at the time of their departure from Canada, export a targeted substance that is in their possession at the time of departure if
(b) the individual is exporting the substance
(c) the substance is required to meet the medical needs of the individual or animal for whose benefit it is prescribed; and
(d) the quantity exported does not exceed the lesser of
PART 6Test Kits
(a) a registration number has been issued for the test kit under subsections 72(1) or 75(2) and the number has not been cancelled under section 74;
(b) the test kit is labelled with
(i) the registration number, and
(c) the test kit is sold, provided, sent, delivered, transported, imported or exported for a medical, laboratory, industrial, educational, law administration or enforcement, or research purpose.
(2) An individual who does not hold a dealer’s licence may possess a test kit that contains a targeted substance set out in Part 2 of Schedule 1 if the test kit is labelled with its registration number.
- SOR/2010-223, s. 32
Marginal note:Application for a registration number
71 (1) The manufacturer or assembler of a test kit or, if the test kit is manufactured or assembled pursuant to a custom order, the person for whom the test kit was manufactured or assembled, may apply for a registration number for the test kit by submitting to the Minister an application containing
(a) the brand name of the test kit;
(b) particulars of the design and construction of the test kit;
(b.1) a statement of the proposed use of the test kit;
(c) a detailed description of the targeted substance contained in the test kit, including
(d) a detailed description of each other substance contained in the test kit, including
(e) the directions for use of the test kit.
Marginal note:Statement by signatory
(2) An application for the registration of a test kit must
- SOR/2010-223, ss. 33, 42(E)
Marginal note:Issuance of a registration number
72 (1) Subject to subsection (2), the Minister must, after examining the information and documents required under sections 11 and 71, issue a registration number for the test kit to the applicant if the applicant demonstrates that the test kit is designed to be used solely for a medical, laboratory, industrial, educational, law administration or enforcement, or research purpose.
(2) The Minister must refuse to issue a registration number if the Minister has reasonable grounds to believe that
(a) the test kit poses a risk to security, public health or safety, including the risk of the targeted substance in the test kit being diverted to an illicit market or use, because
(i) the total amount of the targeted substance in the test kit is too high, or
(ii) the adulterating or denaturing agent in the test kit is not likely to prevent or deter consumption of the targeted substance in the test kit by a human or animal or the administration of that substance to a human or animal; or
(b) the test kit is likely to be used for a purpose other than those set out in subsection (1).
- SOR/2010-223, ss. 34, 43(F)
- Date modified: